Cytisine superior to nicotine replacement for smoking cessation in motivated users
The Brown University Psychopharmacology Update2015Vol. 26(4), pp. 1–6
Abstract
A New Zealand smoking cessation study that compared 25 days of treatment with the plant‐based alkaloid cytisine vs. 8 weeks of nicotine replacement therapy found better abstinence outcomes with cytisine. The partial agonist of nicotinic acetylcholine receptors exceeded the expectations of researchers, who had hypothesized that cytisine would be at least as effective as nicotine replacement therapy in helping smokers to quit.
Related Papers
- → Cytisine for smoking cessation(2018)34 cited
- → Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation(2008)32 cited
- → Partial nicotinic acetylcholine (α4β2) agonists as promising new medications for smoking cessation(2008)5 cited
- → Nicotine receptor partial agonists for smoking cessation(2011)187 cited
- → Nicotine receptor partial agonists for smoking cessation(2008)114 cited